Literature DB >> 27358116

An overview of the history, applications, advantages, disadvantages and prospects of gene therapy.

M Jafarlou1, B Baradaran2, T A Saedi3, V Jafarlou4, D Shanehbandi2, M Maralani5, F Othman1.   

Abstract

Gene therapy has become a significant issue in science-related news. The principal concept of gene therapy is an experimental technique that uses genes to treat or prevent disease. Although gene therapy was originally conceived as a way to treat life-threatening disorders (inborn defects, cancers) refractory to conventional treatment, it is now considered for many non–life-threatening conditions, such as those adversely impacting a patient’s quality of life. An extensive range of efficacious vectors, delivery techniques, and approaches for developing gene-based interventions for diseases have evolved in the last decade. The lack of suitable treatment has become a rational basis for extending the scope of gene therapy. The aim of this review is to investigate the general methods by which genes are transferred and to give an overview to clinical applications. Maximizing the potential benefits of gene therapy requires efficient and sustained therapeutic gene expression in target cells, low toxicity, and a high safety profile. Gene therapy has made substantial progress albeit much slower than was initially predicted. This review also describes the basic science associated with many gene therapy vectors and the present progress of gene therapy carried out for various surface disorders and diseases. The conclusion is that, with increased pathobiological understanding and biotechnological improvements, gene therapy will become a standard part of clinical practice.

Entities:  

Mesh:

Year:  2016        PMID: 27358116

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  8 in total

1.  Relationship between IL-10 gene -819C/T polymorphism and the risk of inflammatory bowel disease: a meta-analysis.

Authors:  Haien Wu; JingJing Guo; Yajun He; Hekun Yin; Jianchang Shu
Journal:  Afr Health Sci       Date:  2016-09       Impact factor: 0.927

2.  Resveratrol Delivery via Gene Therapy: Entering the Modern Era

Authors:  Gurinder Singh
Journal:  Turk J Pharm Sci       Date:  2022-02-28

Review 3.  An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.

Authors:  Wei Chiu; Ting-Yi Lin; Yun-Chia Chang; Henkie Isahwan-Ahmad Mulyadi Lai; Shen-Che Lin; Chun Ma; Aliaksandr A Yarmishyn; Shiuan-Chen Lin; Kao-Jung Chang; Yu-Bai Chou; Chih-Chien Hsu; Tai-Chi Lin; Shih-Jen Chen; Yueh Chien; Yi-Ping Yang; De-Kuang Hwang
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

Review 4.  Klotho and the Treatment of Human Malignancies.

Authors:  Aishani Sachdeva; Jerome Gouge; Christos Kontovounisios; Stella Nikolaou; Alan Ashworth; Kenneth Lim; Irene Chong
Journal:  Cancers (Basel)       Date:  2020-06-23       Impact factor: 6.639

Review 5.  Gene Therapy Leaves a Vicious Cycle.

Authors:  Reena Goswami; Gayatri Subramanian; Liliya Silayeva; Isabelle Newkirk; Deborah Doctor; Karan Chawla; Saurabh Chattopadhyay; Dhyan Chandra; Nageswararao Chilukuri; Venkaiah Betapudi
Journal:  Front Oncol       Date:  2019-04-24       Impact factor: 6.244

6.  Phosphorothioate-DNA bacterial diet reduces the ROS levels in C. elegans while improving locomotion and longevity.

Authors:  Qiang Huang; Ruohan Li; Tao Yi; Fengsong Cong; Dayong Wang; Zixin Deng; Yi-Lei Zhao
Journal:  Commun Biol       Date:  2021-11-25

7.  Kinetic Modeling to Accelerate the Development of Nucleic Acid Formulations.

Authors:  Esther H Roh; Thomas H Epps; Millicent O Sullivan
Journal:  ACS Nano       Date:  2021-10-12       Impact factor: 18.027

Review 8.  Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments.

Authors:  Hossein Ghanbarian; Shahin Aghamiri; Mohamad Eftekhary; Nicole Wagner; Kay-Dietrich Wagner
Journal:  Cells       Date:  2021-03-08       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.